About this trial
In order to prevent sarcopenia in intensive care patients and to guide nutritional therapy, evaluation of muscle thickness with ultrasonography is a modern, simple and non-invasive procedure routinely performed by Anesthesiology and Reanimation specialists. Sarcopenia in intensive care patients has been demonstrated in many studies. It has been studied that routine examination of changes in rectus femoris muscle thickness by ultrasonography is a predictor of sarcopenia. However, the muscles in the neck region, such as the sternocleidomastoid muscle, which are easy to examine, have not been studied very well. There is no study in the literature with the sternocleidomastoid muscle. For this reason, we decided to examine the relationship of sternocleidomastoid muscle thickness with patient characteristics, treatments, feeding route and type, feeding time, length of stay in intensive care unit, as in routine measurements of rectus femoris muscle thickness by ultrasonography.
Eligibility criteria
Qualifiers
Patients who are expected to be followed up in the intensive care unit for at least 1 week
Patients over 18 years old
Disqualifiers
Patients under 18 years of age
Head-neck, femur trauma patients
Those with a diagnosis of primary neuromuscular disease
Those who have a condition that prevents imaging in the body parts where ultrasonography is planned
Trial design
Treatments tested in this trial
- Muscle thickness measurement